Not applicableStudy completedNCT06016283What this trial is testingSex Impact on Long-term Outcomes of LDKTWho this might be right forKidney Transplant Failure and RejectionGender Erasmus Medical Center 1,276
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07539857What this trial is testingBelimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitizedWho this might be right forKidney Transplant Rejection Leiden University Medical Center 25
Testing effectiveness (Phase 2)WithdrawnNCT03606746What this trial is testingCellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney TransplantsWho this might be right forKidney Transplant Rejection Medeor Therapeutics, Inc.
Post-approval studies (Phase 4)Study completedNCT00113269What this trial is testingSafety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant RecipientsWho this might be right forKidney Transplantation Astellas Pharma Inc 501
Post-approval studies (Phase 4)Study completedNCT03511560What this trial is testingEnvarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney TransplantationWho this might be right forRenal Transplant RejectionKidney Transplant Failure and Rejection Columbia University 50
Post-approval studies (Phase 4)Study completedNCT04225988What this trial is testingComparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Cedars-Sinai Medical Center 20
Not applicableStudy completedNCT02633826What this trial is testingPre-formed Alloreactivity in Renal Transplant RecipientsWho this might be right forKidney TransplantationAcute Graft Rejection Martina Sester 190
Not applicableStudy completedNCT01353417What this trial is testingNon-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft RejectionWho this might be right forChronic Kidney Insufficiency Sandoz 102
Very early researchEnded earlyNCT01318915What this trial is testingResearch Study of ATG and Rituximab in Renal TransplantationWho this might be right forRenal Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00001858What this trial is testingMonitoring for Tolerance to Kidney or Combined Kidney-Pancreas TransplantsWho this might be right forGraft RejectionKidney Disease National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 294
Not applicableLooking for participantsNCT06025240What this trial is testingExpanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant RecipientsWho this might be right forKidney TransplantRenal Transplant FailureKidney Transplant Rejection+5 more Liverpool University Hospitals NHS Foundation Trust 282
Not applicableEnded earlyNCT04711850What this trial is testingAn Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMRWho this might be right forKidney Transplant Rejection Hansa Biopharma AB 18
Early research (Phase 1)Not Yet RecruitingNCT06852625What this trial is testingAutologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Fundacion Clinic per a la Recerca Biomédica 30
Not applicableNot Yet RecruitingNCT07091214What this trial is testingMolecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS StudyWho this might be right forKidney Rejection Transplant Paris Translational Research Center for Organ Transplantation 600
Testing effectiveness (Phase 2)UnknownNCT01154387What this trial is testingEvaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant RejectionWho this might be right forEnd Stage Renal DiseaseRenal Transplant Tolera Therapeutics, Inc 85
Testing effectiveness (Phase 2)Looking for participantsNCT07053462What this trial is testingCRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection RiskWho this might be right forEnd-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Testing effectiveness (Phase 2)Study completedNCT00078559What this trial is testingCombination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in AdultsWho this might be right forKidney TransplantationKidney Disease University of Wisconsin, Madison 10
Not applicableStudy completedNCT03517982What this trial is testingGeneric Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in JordanWho this might be right forAcute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant Hikma Pharmaceuticals LLC 12
Not applicableStudy completedNCT00729248What this trial is testingThe Differential Effects of 3 Different ImmunosuppressiveWho this might be right forImmunosuppressionKidney Transplantation Northwestern University 12
Testing effectiveness (Phase 2)Study completedNCT00183248What this trial is testingUsing Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant PatientsWho this might be right forKidney TransplantationKidney DiseaseKidney Failure University of Miami 9